Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Hainaut

Showing results (111-120 of 280) with videos related to

Pageof 28
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|April 18, 2002
Evaluating the arrayed primer extension resequencing assay of TP53 tumor suppressor geneNeeme Tõnisson, Jana Zernant, Ants Kurg, et al.
Molecular Carcinogenesis|September 13, 2007
Inducible nitric oxide synthase, nitrotyrosine and p53 mutations in the molecular pathogenesis of Barrett's esophagus and esophageal adenocarcinomaNadine M Vaninetti, Laurette Geldenhuys, Geoffrey A Porter, et al.
Chemosphere|October 29, 2025
Simultaneous exogenous application of trans-zeatin riboside and EDDS: A powerful strategy to improve heavy metals phytoextraction efficiency by Miscanthus x giganteus LStanley Lutts, Nolan Regnier, Zahra Kiamarsi, et al.
Cancer Letters|December 25, 2004
p16 expression in Barrett's esophagus and esophageal adenocarcinoma: association with genetic and epigenetic alterationsLaura J Hardie, S Jane Darnton, Yvonne L Wallis, et al.
Oncogene|July 12, 2005
249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinomaGregory D Kirk, Olufunmilayo A Lesi, Maimuna Mendy, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 15, 2010
Aetiological differences in demographical, clinical and pathological characteristics of hepatocellular carcinoma in The GambiaNsikak J Umoh, Olufunmilayo A Lesi, Maimuna Mendy, et al.
The Journal of Clinical Investigation|October 14, 2010
Dual function of MyD88 in RAS signaling and inflammation, leading to mouse and human cell transformationIsabelle Coste, Katy Le Corf, Alain Kfoury, et al.
Cancer Letters|February 17, 2009
Role of p53 in the induction of cyclooxygenase-2 by cisplatin or paclitaxel in non-small cell lung cancer cell linesMariana Lemos Duarte, Emanuela de Moraes, Elizangela Pontes, et al.
BMC Cancer|December 20, 2007
Biological characterization of two xenografts derived from human CUPs (carcinomas of unknown primary)Delphine Lequin, Karim Fizazi, Saloua Toujani, et al.
Hepatology (Baltimore, Md.)|September 29, 2011
Identification of osteopontin as a novel marker for early hepatocellular carcinomaSufen Shang, Amelie Plymoth, Shaokui Ge, et al.
Pageof 28

Showing results (111-120 of 280) with videos related to

Sort By:
Pageof 28
Proceedings of the National Academy of Sciences of the United States of America|April 18, 2002
Evaluating the arrayed primer extension resequencing assay of TP53 tumor suppressor geneNeeme Tõnisson, Jana Zernant, Ants Kurg, et al.
Molecular Carcinogenesis|September 13, 2007
Inducible nitric oxide synthase, nitrotyrosine and p53 mutations in the molecular pathogenesis of Barrett's esophagus and esophageal adenocarcinomaNadine M Vaninetti, Laurette Geldenhuys, Geoffrey A Porter, et al.
Chemosphere|October 29, 2025
Simultaneous exogenous application of trans-zeatin riboside and EDDS: A powerful strategy to improve heavy metals phytoextraction efficiency by Miscanthus x giganteus LStanley Lutts, Nolan Regnier, Zahra Kiamarsi, et al.
Cancer Letters|December 25, 2004
p16 expression in Barrett's esophagus and esophageal adenocarcinoma: association with genetic and epigenetic alterationsLaura J Hardie, S Jane Darnton, Yvonne L Wallis, et al.
Oncogene|July 12, 2005
249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinomaGregory D Kirk, Olufunmilayo A Lesi, Maimuna Mendy, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 15, 2010
Aetiological differences in demographical, clinical and pathological characteristics of hepatocellular carcinoma in The GambiaNsikak J Umoh, Olufunmilayo A Lesi, Maimuna Mendy, et al.
The Journal of Clinical Investigation|October 14, 2010
Dual function of MyD88 in RAS signaling and inflammation, leading to mouse and human cell transformationIsabelle Coste, Katy Le Corf, Alain Kfoury, et al.
Cancer Letters|February 17, 2009
Role of p53 in the induction of cyclooxygenase-2 by cisplatin or paclitaxel in non-small cell lung cancer cell linesMariana Lemos Duarte, Emanuela de Moraes, Elizangela Pontes, et al.
BMC Cancer|December 20, 2007
Biological characterization of two xenografts derived from human CUPs (carcinomas of unknown primary)Delphine Lequin, Karim Fizazi, Saloua Toujani, et al.
Hepatology (Baltimore, Md.)|September 29, 2011
Identification of osteopontin as a novel marker for early hepatocellular carcinomaSufen Shang, Amelie Plymoth, Shaokui Ge, et al.
Pageof 28